Novel transcellular interaction: conversion of granulocyte-derived leukotriene A4 to cysteinyl-containing leukotrienes by human platelets.
Human platelets dose-dependently converted exogenous leukotriene A4 to leukotriene C4 and efficiently metabolized this compound to leukotrienes D4 and E4. Neither of these compounds were produced after stimulation of human platelet suspensions with ionophore A23187. After LTA4 incubation of subcellular fractions, formation of leukotriene C4 was exclusively observed in the particulate fraction and was separable from the classical glutathione S-transferase activity. This suggested the presence of a specific leukotriene C4 synthase in human platelets. Addition of physiological amounts of autologous platelets to human granulocyte suspensions significantly increased ionophore A23187-induced formation of leukotriene C4. In contrast, the production of leukotriene B4 was decreased. After preincubation of platelets with [35S]cysteine, 35S-labeled leukotriene C4 was produced by A23187-stimulated platelet-granulocyte suspensions, strongly indicating a transcellular biosynthesis of this compound.
Edenius
C
C
Department of Physiological Chemistry, Karolinska Institutet, Stockholm, Sweden.
Heidvall
K
K
Lindgren
J A
JA
D001792:Blood Platelets / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D003545:Cysteine / Q000378:metabolism*; D005982:Glutathione Transferase / Q000378:metabolism; D006098:Granulocytes / Q000378:metabolism*; D006801:Humans; D017572:Leukotriene A4; D017999:Leukotriene E4; D015289:Leukotrienes / Q000378:metabolism* / Q000494:pharmacology; D013189:SRS-A / Q000031:analogs & derivatives* / Q000096:biosynthesis* / Q000494:pharmacology; D013347:Subcellular Fractions / Q000378:metabolism
D017572:Leukotriene A4; D015289:Leukotrienes; D013189:SRS-A; D000001:Calcimycin; D017999:Leukotriene E4; D005982:Glutathione Transferase; C041116:leukotriene-C4 synthase; D003545:Cysteine